XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Restatement of Previously Issued Financial Statements (Tables)
6 Months Ended
Jun. 30, 2022
Accounting Changes and Error Corrections [Abstract]  
Schedule of Restatement of Previously Issued Financial Statements

The Company’s condensed consolidated financial statements as of and for the three and six months ended June 30, 2022 included in this Form 10-Q/A have been restated to correct the errors as follows:

 

 

 

As of June 30. 2022

 

Condensed Consolidated Balance Sheet

 

As Previously Reported

 

 

Adjustments

 

 

As Restated

 

Earnout liability

 

$

64,400

 

 

$

(32,200

)

 

$

32,200

 

Total liabilities

 

 

218,834

 

 

 

(32,200

)

 

 

186,634

 

Retained earnings (Accumulated deficit)

 

$

(24,952

)

 

$

(24,192

)

 

$

(49,144

)

biote Corp.’s stockholders’ equity (deficit)

 

 

(24,951

)

 

 

(24,192

)

 

 

(49,143

)

Noncontrolling interest

 

 

(78,561

)

 

 

56,392

 

 

 

(22,169

)

Total stockholders’ equity (deficit)

 

 

(103,512

)

 

 

32,200

 

 

 

(71,312

)

 

 

 

Three Months Ended June 30, 2022

 

Condensed Consolidated Statement of Income and Comprehensive Income

 

As Previously Reported

 

 

Adjustments

 

 

As Restated

 

Gain from change in fair value of earnout liability

 

$

123,350

 

 

$

(61,670

)

 

$

61,680

 

Total other income (expense), net

 

 

125,598

 

 

 

(61,670

)

 

 

63,928

 

Income (loss) before provision for income taxes

 

 

39,995

 

 

 

(61,670

)

 

 

(21,675

)

Net income (loss)

 

 

40,341

 

 

 

(61,670

)

 

 

(21,329

)

Less: Net loss attributable to noncontrolling interest

 

 

(75,115

)

 

 

56,392

 

 

 

(18,723

)

Net income (loss) attributable to biote Corp.

 

 

115,456

 

 

 

(118,062

)

 

 

(2,606

)

Comprehensive income (loss)

 

$

40,336

 

 

$

(61,670

)

 

$

(21,334

)

 

 

 

 

 

 

 

 

 

 

Net income (loss) per common share

 

 

 

 

 

 

 

 

 

Basic

 

$

15.24

 

 

$

(15.59

)

 

$

(0.34

)

Diluted

 

$

2.01

 

 

$

(2.35

)

 

$

(0.34

)

 

 

 

Six Months Ended June 30, 2022

 

Condensed Consolidated Statement of Income and Comprehensive Income

 

As Previously Reported

 

 

Adjustments

 

 

As Restated

 

Gain from change in fair value of earnout liability

 

$

123,350

 

 

$

(61,670

)

 

$

61,680

 

Total other income (expense), net

 

 

125,249

 

 

 

(61,670

)

 

 

63,579

 

Income (loss) before provision for income taxes

 

 

49,409

 

 

 

(61,670

)

 

 

(12,261

)

Net income (loss)

 

 

49,691

 

 

 

(61,670

)

 

 

(11,979

)

Less: Net loss attributable to noncontrolling interest

 

 

(65,765

)

 

 

56,392

 

 

 

(9,373

)

Net income (loss) attributable to biote Corp.

 

 

115,456

 

 

 

(118,062

)

 

 

(2,606

)

Comprehensive income (loss)

 

$

49,692

 

 

$

(61,670

)

 

$

(11,978

)

 

 

 

 

 

 

 

 

 

 

Net income (loss) per common share

 

 

 

 

 

 

 

 

 

Basic

 

$

15.24

 

 

$

(15.58

)

 

$

(0.34

)

Diluted

 

$

2.01

 

 

$

(2.35

)

 

$

(0.34

)

 

 

 

 

Six Months Ended June 30, 2022

 

Condensed Consolidated Statement of Cash Flows

 

As Previously Reported

 

 

Adjustments

 

 

As Restated

 

Net income (loss)

 

$

49,691

 

 

$

(61,670

)

 

$

(11,979

)

Gain from change in fair value of earnout liability

 

$

(123,350

)

 

$

61,670

 

 

$

(61,680

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Retained

 

Accumulated

 

Stockholders’

 

 

 

Total

 

 

 

 

 

 

Additional

 

Earnings /

 

Other

 

Equity (Deficit)

 

Non-

 

Stockholders’

 

Condensed Consolidated Statement of

Members’ Equity

 

Class A Common Stock

 

Class V Voting Stock

 

Paid-in

 

(Accumulated

 

Comprehensive

 

Attributable to

 

controlling

 

Equity

 

Stockholders' Equity (Deficit)

Units

 

Amount

 

Shares

 

Amount

 

Shares

 

Amount

 

Capital

 

Deficit)

 

Income (Loss)

 

biote Corp.

 

Interest

 

(Deficit)

 

Business Combination: Reverse recapitalization on May 26, 2022 (As previously reported)

 

(982,800

)

$

 

 

7,574,271

 

$

1

 

 

48,565,824

 

$

5

 

$

 

$

(207,498

)

$

 

$

(207,492

)

$

 

$

(207,492

)

Adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

93,870

 

 

 

 

93,870

 

 

 

 

93,870

 

Business Combination: Reverse recapitalization on May 26, 2022 (As restated)

 

(982,800

)

 

 

 

7,574,271

 

 

1

 

 

48,565,824

 

 

5

 

 

 

 

(113,628

)

 

 

 

(113,622

)

 

 

 

(113,622

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) after May 26, 2022 (As previously reported)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

115,456

 

 

 

 

115,456

 

 

(74,908

)

 

40,548

 

Adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(118,062

)

 

 

 

(118,062

)

 

56,392

 

 

(61,670

)

Net loss after May 26, 2022 (As restated)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2,606

)

 

 

 

(2,606

)

 

(18,516

)

 

(21,122

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at June 30, 2022 (As previously reported)

 

 

 

 

 

7,574,271

 

 

1

 

 

48,565,824

 

 

5

 

 

 

 

(24,952

)

 

(5

)

 

(24,951

)

 

(78,561

)

 

(103,512

)

Net impact of adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(24,192

)

 

 

 

(24,192

)

 

56,392

 

 

32,200

 

Balance at June 30, 2022 (As restated)

 

 

$

 

 

7,574,271

 

$

1

 

 

48,565,824

 

$

5

 

$

 

$

(49,144

)

$

(5

)

$

(49,143

)

$

(22,169

)

$

(71,312

)